bio:cap 2026: International Life Science & AI Festival

Intavis Peptide Services is pleased to participate in bio: Cap 2026, taking place from June 9 to 11, 2026, at CityCube Berlin in Berlin, Germany.

Hosted by Messe Berlin, bio: Cap 2026 is an international Life Science and AI Investival that brings together innovators, investors, industry leaders, policymakers, start-ups, scale-ups, and leading experts from science and medicine. The event focuses on the intersection of Life Sciences, artificial intelligence, biotech, diagnostics, pharma, investment, and innovation, creating a dynamic platform for exchange, collaboration, and future-focused partnerships.

What to expect at bio: Cap 2026:

• High-level keynotes and discussions on Life Sciences, AI, biotech, TechBio, diagnostics, and pharma
• Insights into how artificial intelligence is shaping research, drug discovery, diagnostics, and healthcare innovation
• Curated matchmaking opportunities connecting innovators, investors, industry leaders, and decision-makers
• Deep-dive sessions exploring investment, commercialization, and the translation of scientific breakthroughs into scalable solutions
• Networking formats designed to foster collaboration across science, industry, capital, and policy
• A festival-inspired atmosphere in Berlin, one of Europe’s leading hubs for research, entrepreneurship, and innovation

Intavis Peptide Services will be represented at bio: Cap 2026 by Dr. Oliver Reimann, Head of Sales, BD & Marketing. He will be available to discuss advanced peptide synthesis solutions and how Intavis Peptide Services supports innovation across research, drug discovery, and development.

Whether you are advancing Life Science innovation, exploring AI-driven opportunities, seeking investment insights, or looking to build strategic partnerships, bio: Cap 2026 offers a valuable platform to connect with key stakeholders shaping the future of healthcare, biotechnology, and scientific innovation.